Vaccine Assay Development Panel Discussion

Accelerating vaccine development timelines with experience, expertise and automation

In this panel discussion, you will learn about the development of vaccine assays, the different types of assays available, specific expertise and tools needed for development, and FDA approval. This panel features commentary from the following experts:

Cyrille Bonhomme, Ph.D.
Director of PPD Laboratory services, PPD (N.C., U.S.), part of Thermo Fisher Scientific

Liang Zhu
Director of Clinical Biomarker Laboratories, Moderna Therapeutics (Mass., U.S.)

Professor Petro Terblanche
Managing Director, Afrigen Biologics (Cape Town, South Africa)

Nick Diamond
Regulatory Lawyer, Jackson Walker (Texas, U.S.)